| Dr Jill Marie Arganbright, MD | |
|
2401 Gillham Rd, Kansas City, MO 64108-4619 | |
| (816) 234-3000 | |
| Not Available |
| Full Name | Dr Jill Marie Arganbright |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology - Pediatric Otolaryngology |
| Location | 2401 Gillham Rd, Kansas City, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912165135 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YP0228X | Otolaryngology - Pediatric Otolaryngology | 2014020139 (Missouri) | Primary |
| 207YP0228X | Otolaryngology - Pediatric Otolaryngology | 04-37281 (Kansas) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jill Marie Arganbright, MD 2401 Gillham Rd, Kansas City, MO 64108-4619 Ph: (816) 234-3000 | Dr Jill Marie Arganbright, MD 2401 Gillham Rd, Kansas City, MO 64108-4619 Ph: (816) 234-3000 |
News Archive
Pediatricians now have a practical tool to help determine whether children with chronic diseases like Crohn's, juvenile arthritis and anorexia nervosa or those undergoing cancer treatment are at increased risk for bone mass deficiencies, fracture or osteoporosis as they get older, according to a new study whose lead author is a researcher at Cincinnati Children's Hospital Medical Center.
The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years.
The intercellular bacteria "Candidatus Neoehrlichia", as e.g. Borrelia, can be transferred by ticks. Approx. 4.2 % of indigenous ticks are infected with this rarely explored bacterium which, until today, has been exclusively identified as pathogenic bacterium in patients with an impairment of the immune system, such as in case of leukaemia, rheumatism or after organ transplantation.
At its annual investor R&D Day today, Micromet, Inc. (Nasdaq: MITI) outlined the design of a registration study for the Company's lead product candidate blinatumomab in acute lymphocytic leukemia (ALL), highlighted clinical data demonstrating the breadth of blinatumomab's activity in B-cell non-Hodgkin's lymphomas and announced plans to expand clinical development of blinatumomab in the U.S.
In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, reveal the intricate mechanisms involved in the enzyme that governs DNA duplication during cell division.
› Verified 2 days ago
Dr. Kim Ann Suk Baker, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3042 | |
Dr. Bart C Patenaude, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 15 E 54th St, Kansas City, MO 64110 Phone: 816-519-3013 | |
Dr. Ann Bailey Robinson, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1004 Carondelet Dr, Suite 450, Kansas City, MO 64114 Phone: 816-942-7200 Fax: 816-941-2767 | |
Dr. Pamela Nicklaus, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Robert Weatherly, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 | |
Joseph R Guastello, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4320 Wornall Rd, Ste 512, Kansas City, MO 64111 Phone: 816-932-8663 | |
Dr. Thomas Cotton, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2401 Gillham Rd, Kansas City, MO 64108 Phone: 816-234-3000 |